Market Overview:
The global non-selective ELISA kits market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for ELISA kits for various applications such as hospitals and clinics, research institutions, bio science companies, and others. Additionally, the growing awareness about early diagnosis and treatment of diseases is also contributing to the growth of this market.
Product Definition:
A non-selective ELISA kit is a laboratory tool used to detect the presence of antibodies in a sample. The importance of these kits lies in their ability to detect antibodies from a variety of sources, including viruses, bacteria, and other pathogens.
Direct ELISA:
Direct ELISA, also known as non-selective ELISA is a type of enzyme immunoassay used for the detection of specific antibodies. It is an indirect test that measures the presence of an antibody in the blood sample. The test does not indicate whether or not there are any diseases present in the body but rather helps to identify if a person has been exposed to any particular disease-causing agent such as bacteria, virus or fungus by testing for antibodies against these agents.
Sandwich ELISA:
A sandwich ELISA is an assay that comprises of two antibodies, the second antibody being conjugated to a radioactive element or enzyme. The radioactive element or enzyme activity can be detected by using a substrate specific for the detection of that particular activity.
Theory: how does it work? According to this article, when an antibody binds to its antigen, both are transported into cells nuclei where they colocalize and remain for some time.
Application Insights:
The research institutions segment dominated the global non-selective ELISA kits market in 2017. This is attributed to increasing government funding for R&D and growing emphasis on biomarker-based diagnostics. Non-selective ELISA tests are used as a primary test method for the detection of antibodies in human serum or plasma samples, which are obtained from patients suffering from an infectious disease such as chickenpox, hepatitis A & B, typhoid fever etc. The application of non-selective ELISA tests has been further extended to include autoimmune diseases such as rheumatoid arthritis and lupus erythematosus.
The hospitals and clinics segment is expected to grow at a lucrative rate over the forecast period owing to rising awareness about preventive healthcare measures along with an increase in spending capacity of consumers due to robust economic growth coupled with improved standard of living globally since 1980s (OECD countries).
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate for technologically advanced products are some of the factors responsible for its large share. Furthermore, increasing government funding to promote R&D activities is also expected to contribute towards growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and growing demand for better healthcare services leading to an increase in demand for diagnostic tests. Moreover, a rise in investments by various organizations promoting research activities will boost industry expansion over this period. In addition, economic development coupled with improvement in healthcare facilities will further propel regional market development during the forecast years from 2018-2030 (USD Million).
Latin America region is anticipated grow at a significant CAGR due ELISA test being used widely across different industries such as food & beverage.
Growth Factors:
- Increasing demand for non-selective ELISA kits from the biotechnology and pharmaceutical industries for drug discovery and development applications.
- Growing use of non-selective ELISA kits in research laboratories for studying protein interactions, biomarker detection, and other molecular biology applications.
- Rising demand for multiplexed assays that can detect several analytes simultaneously using a single kit.
- Advances in technology that are making non-selective ELISA kits more sensitive, accurate, and reliable than ever before.
- Increasing awareness among researchers about the benefits of using non-selective ELISA kits over traditional methods such as Western blotting or immunoprecipitation
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-Selective ELISA Kits Market Research Report
By Type
Direct ELISA, Sandwich ELISA, Indirect ELISA, Competitive ELISA
By Application
Hospitals and Clinics, Research Institutions, Bio Science Companies, Others
By Companies
R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, Abcam, ALPCO, Enzo Life Sciences, BioMerieux, EMD Millipore, BioLegend, LOEWE Biochemica, Mercodia, Cusabio, Shanghai Kehua Bio-engineering
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
126
Number of Tables & Figures
89
Customization Available
Yes, the report can be customized as per your need.
Global Non-Selective ELISA Kits Market Report Segments:
The global Non-Selective ELISA Kits market is segmented on the basis of:
Types
Direct ELISA, Sandwich ELISA, Indirect ELISA, Competitive ELISA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Research Institutions, Bio Science Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- R&D Systems
- Thermo Fisher Scientific
- Ortho Clinical Diagnostics
- BD Biosciences
- ZEUS Scientific
- Bio-Rad Laboratories
- Abcam
- ALPCO
- Enzo Life Sciences
- BioMerieux
- EMD Millipore
- BioLegend
- LOEWE Biochemica
- Mercodia
- Cusabio
- Shanghai Kehua Bio-engineering
Highlights of The Non-Selective ELISA Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Direct ELISA
- Sandwich ELISA
- Indirect ELISA
- Competitive ELISA
- By Application:
- Hospitals and Clinics
- Research Institutions
- Bio Science Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-Selective ELISA Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Non-selective ELISA kits are used to detect the presence of a specific antigen in a sample.
Some of the major companies in the non-selective elisa kits market are R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, Abcam, ALPCO, Enzo Life Sciences, BioMerieux, EMD Millipore, BioLegend, LOEWE Biochemica, Mercodia, Cusabio, Shanghai Kehua Bio-engineering.
The non-selective elisa kits market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Non-Selective ELISA Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Non-Selective ELISA Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Non-Selective ELISA Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Non-Selective ELISA Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Non-Selective ELISA Kits Market Size & Forecast, 2018-2028
4.5.1 Non-Selective ELISA Kits Market Size and Y-o-Y Growth
4.5.2 Non-Selective ELISA Kits Market Absolute $ Opportunity
Chapter 5 Global Non-Selective ELISA Kits Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Non-Selective ELISA Kits Market Size Forecast by Type
5.2.1 Direct ELISA
5.2.2 Sandwich ELISA
5.2.3 Indirect ELISA
5.2.4 Competitive ELISA
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Non-Selective ELISA Kits Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Non-Selective ELISA Kits Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Research Institutions
6.2.3 Bio Science Companies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Non-Selective ELISA Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Non-Selective ELISA Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Non-Selective ELISA Kits Analysis and Forecast
9.1 Introduction
9.2 North America Non-Selective ELISA Kits Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Non-Selective ELISA Kits Market Size Forecast by Type
9.6.1 Direct ELISA
9.6.2 Sandwich ELISA
9.6.3 Indirect ELISA
9.6.4 Competitive ELISA
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Non-Selective ELISA Kits Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Research Institutions
9.10.3 Bio Science Companies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Non-Selective ELISA Kits Analysis and Forecast
10.1 Introduction
10.2 Europe Non-Selective ELISA Kits Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Non-Selective ELISA Kits Market Size Forecast by Type
10.6.1 Direct ELISA
10.6.2 Sandwich ELISA
10.6.3 Indirect ELISA
10.6.4 Competitive ELISA
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Non-Selective ELISA Kits Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Research Institutions
10.10.3 Bio Science Companies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Non-Selective ELISA Kits Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Non-Selective ELISA Kits Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Non-Selective ELISA Kits Market Size Forecast by Type
11.6.1 Direct ELISA
11.6.2 Sandwich ELISA
11.6.3 Indirect ELISA
11.6.4 Competitive ELISA
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Non-Selective ELISA Kits Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Research Institutions
11.10.3 Bio Science Companies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Non-Selective ELISA Kits Analysis and Forecast
12.1 Introduction
12.2 Latin America Non-Selective ELISA Kits Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Non-Selective ELISA Kits Market Size Forecast by Type
12.6.1 Direct ELISA
12.6.2 Sandwich ELISA
12.6.3 Indirect ELISA
12.6.4 Competitive ELISA
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Non-Selective ELISA Kits Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Research Institutions
12.10.3 Bio Science Companies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Non-Selective ELISA Kits Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Non-Selective ELISA Kits Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Non-Selective ELISA Kits Market Size Forecast by Type
13.6.1 Direct ELISA
13.6.2 Sandwich ELISA
13.6.3 Indirect ELISA
13.6.4 Competitive ELISA
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Non-Selective ELISA Kits Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Research Institutions
13.10.3 Bio Science Companies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Non-Selective ELISA Kits Market: Competitive Dashboard
14.2 Global Non-Selective ELISA Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 R&D Systems
14.3.2 Thermo Fisher Scientific
14.3.3 Ortho Clinical Diagnostics
14.3.4 BD Biosciences
14.3.5 ZEUS Scientific
14.3.6 Bio-Rad Laboratories
14.3.7 Abcam
14.3.8 ALPCO
14.3.9 Enzo Life Sciences
14.3.10 BioMerieux
14.3.11 EMD Millipore
14.3.12 BioLegend
14.3.13 LOEWE Biochemica
14.3.14 Mercodia
14.3.15 Cusabio
14.3.16 Shanghai Kehua Bio-engineering
